HDF 치료는 일반 HD와 HDF의 비용 차이가 아직 한국에서 변제되지 않아 전체 HD 환자 중 18%만 적용됐다.
HDF therapy was still not popular, and was applied to only 18% of the whole HD patient population because the cost difference between conventional HD and HDF was still not reimbursed in Korea.